Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALCAFTADINE vs ALEMTUZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALCAFTADINE vs ALEMTUZUMAB: Safety Overview

Metric ALCAFTADINE ALEMTUZUMAB
Total FAERS Reports 465 14,161
Deaths Reported 0 1,417
Death Rate N/A 10.0%
Hospitalizations 4 4,455
Average Patient Age 56.0 yrs 38.9 yrs
% Female Patients 80.3% 63.2%
FDA Approval Date Jul 28, 2010 N/A
Manufacturer Aurohealth LLC Genzyme Corporation
Route OPHTHALMIC INTRAVENOUS
Marketing Status OTC Prescription